Matches in Wikidata for { <http://www.wikidata.org/entity/Q99569270> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q99569270 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99569270 description "scientific article published on 15 September 2020" @default.
- Q99569270 description "wetenschappelijk artikel" @default.
- Q99569270 description "наукова стаття, опублікована 15 вересня 2020" @default.
- Q99569270 name "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 name "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 type Item @default.
- Q99569270 label "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 label "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 prefLabel "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 prefLabel "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 P1433 Q99569270-064451E1-A4F4-4F85-AEB0-B045FD2B5E28 @default.
- Q99569270 P1476 Q99569270-FA17D99A-9F3A-4C00-A88C-7492F5549B1D @default.
- Q99569270 P2093 Q99569270-150E7FCC-BC30-4965-A56A-6A3E18452E33 @default.
- Q99569270 P2093 Q99569270-3170DE63-278B-484A-BFE2-B055FE054F06 @default.
- Q99569270 P2093 Q99569270-33DEDD84-C905-489F-B0F8-3A47554F5DFB @default.
- Q99569270 P2093 Q99569270-343D8D48-A9E5-4BC1-8CD9-1ADA8AEBEC3C @default.
- Q99569270 P2093 Q99569270-3A37DE8A-7AE1-4960-B604-508E710FE4FD @default.
- Q99569270 P2093 Q99569270-3DFDCC7C-4D79-4C05-9A5D-FB6187A75A4A @default.
- Q99569270 P2093 Q99569270-3EB93A8E-6FCB-40C2-AE91-416ABE7EDA76 @default.
- Q99569270 P2093 Q99569270-4EFCFC1B-9CEB-4CDD-B276-F939D7B86671 @default.
- Q99569270 P2093 Q99569270-68A2EF5A-5BD7-4343-94DA-E430DF04F68B @default.
- Q99569270 P2093 Q99569270-6A1F3C3A-74DD-4334-80CC-B61E5CCF94D0 @default.
- Q99569270 P2093 Q99569270-74E7960C-6AAA-4E80-8618-A8CC942660C1 @default.
- Q99569270 P2093 Q99569270-8D4430DE-BF36-41CD-B6C2-79DB941B2575 @default.
- Q99569270 P2093 Q99569270-8DE1CD34-14F7-42AC-A026-657EA2CC95F8 @default.
- Q99569270 P2093 Q99569270-96248F43-08F4-4E8D-8184-17CAE135995C @default.
- Q99569270 P2093 Q99569270-C56B558F-9FCF-4597-A950-F33D465D9CF9 @default.
- Q99569270 P2093 Q99569270-DF1F66CC-83F5-4AC5-A410-91F504AFBF6B @default.
- Q99569270 P2093 Q99569270-E5EBEAFD-27E3-429F-B7A3-BA1A2C0AB98B @default.
- Q99569270 P2093 Q99569270-EC838AD0-1954-4027-8C02-FDAD7DE215BA @default.
- Q99569270 P2093 Q99569270-EE86FE00-32EE-4022-94F0-448D1650C4D1 @default.
- Q99569270 P31 Q99569270-7E3C18D7-5C8E-443E-8348-FBAF0159B583 @default.
- Q99569270 P356 Q99569270-6974C165-7689-4B2B-9123-EDE9F2C5F8E7 @default.
- Q99569270 P577 Q99569270-A24FBE19-E370-4A1E-88AD-C620D7C90CE2 @default.
- Q99569270 P698 Q99569270-FA3868FB-502C-4E74-8D96-A4567092664A @default.
- Q99569270 P921 Q99569270-B1A09052-7CFD-4E78-9CDE-FBE1F1DBD598 @default.
- Q99569270 P921 Q99569270-DDACF98F-D026-457D-8933-65ADFC2ADBBB @default.
- Q99569270 P356 J.AMJCARD.2020.09.015 @default.
- Q99569270 P698 32946862 @default.
- Q99569270 P1433 Q2208417 @default.
- Q99569270 P1476 "Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis" @default.
- Q99569270 P2093 "Andreas Heibges" @default.
- Q99569270 P2093 "Axel Versen" @default.
- Q99569270 P2093 "Carsten Schürfeld" @default.
- Q99569270 P2093 "Christina Taylan" @default.
- Q99569270 P2093 "Claus P Schmitt" @default.
- Q99569270 P2093 "Günter Klaus" @default.
- Q99569270 P2093 "Holger Stein" @default.
- Q99569270 P2093 "Jens König" @default.
- Q99569270 P2093 "Joenna Driemeyer" @default.
- Q99569270 P2093 "Juergen R Schaefer" @default.
- Q99569270 P2093 "Jun Oh" @default.
- Q99569270 P2093 "Lars Pape" @default.
- Q99569270 P2093 "Lutz T Weber" @default.
- Q99569270 P2093 "Matthias Galiano" @default.
- Q99569270 P2093 "Michael Koziolek" @default.
- Q99569270 P2093 "Rainer Büscher" @default.
- Q99569270 P2093 "Ralf Spitthöver" @default.
- Q99569270 P2093 "Reinhard Klingel" @default.
- Q99569270 P2093 "Tobias A Marsen" @default.
- Q99569270 P31 Q13442814 @default.
- Q99569270 P356 "10.1016/J.AMJCARD.2020.09.015" @default.
- Q99569270 P577 "2020-09-15T00:00:00Z" @default.
- Q99569270 P698 "32946862" @default.
- Q99569270 P921 Q114049690 @default.
- Q99569270 P921 Q15815863 @default.